A carregar...
Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
BACKGROUND AND AIM: Thrombocytopenia is common in people with chronic liver disease, who frequently undergo invasive procedures. To minimize the risk of bleeding, prophylactic platelet transfusions have traditionally been used but carry many risks. The aim of this study was to evaluate the cost-effe...
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7500829/ https://ncbi.nlm.nih.gov/pubmed/32982341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S262772 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|